|
Item 8.01 |
Other Events. |
As previously announced in its Current Report on Form 8-K filed with the Securities and Exchange Commission on April 26, 2024, on April 25, 2024, Annovis Bio, Inc. (the "Registrant") entered into a Common Stock Purchase Agreement with an equity line investor (the "Agreement"). On May 2, 2024 the Parties closed the transactions contemplated by the Agreement. A copy of the opinion of Loeb & Loeb LLP in connection with the issuance of the securities is filed as Exhibit 5.1 hereto.
Attachments
Disclaimer
Annovis Bio Inc. published this content on 02 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 May 2024 20:49:40 UTC.